2500439 part 1
Study for the treatment of recurrent skin inflammations (Part 1)
18 - 55
- Male
- Female
May - July
> 14 days
4
Compensation provided
Are you
- a healthy male or infertile* female
- between 18 and 55 years (inclusive)
- with a BMI between 18 and 32 kg/m² (inclusive)
- who does not smoke or quit smoking at least 3 months prior to screening
- nicotine-containing products (e.g. nicotine patches and e-cigarettes) must be discontinued at least 3 months prior to screening
- who does not use daily medication
*postmenopausal (no menses for at least 12 months), removal of the uterus, removal of both ovaries or fallopian tubes
What does this trial involve?
In study 2500439 part 1, SGS CPU is investigating the treatment of recurrent skin inflammations. During +/- 9 weeks you will have the following appointments:
- a screening visit
- a stay of 16 days (15 nights)
- 3 morning return visits
- an end of trial visit
Take part in this trial and
- contribute to the medicine of tomorrow
- a compensation will be provided
This study was approved by the competent Belgian health authorities and an independent ethics committee.
View information leaflet Panel A
View information leaflet Panel B
